Table 7 Optimal predicted HLA-I-restricted epitopes selected from HPV-33 E6 and E7
From: Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China
Target Protein | Start | Length | Peptide | Percentile Rank | Binding Core in HLA-II predicted epitopes |
|---|---|---|---|---|---|
HPV-33 E6 | 41 | 14 | EVYDFAFADLTVVY | 0.1 | YDFAFADLT/DFAFADLTV/FAFADLTVV |
42 | 14 | VYDFAFADLTVVYR | 0.1 | YDFAFADLT/DFAFADLTV/FAFADLTVV | |
43 | 14 | YDFAFADLTVVYRE | 0.1 | YDFAFADLT/DFAFADLTV/FAFADLTVV | |
44 | 14 | DFAFADLTVVYREG | 0.1 | DFAFADLTV/FAFADLTVV | |
45 | 14 | FAFADLTVVYREGN | 0.1 | FAFADLTVV | |
HPV-33 E7 | 52 | 10 | YYIVTCCHTC | 0.6 | YYIVTCCHT |
59 | 8 | HTCNTTVR | 0.6 | ||
77 | 8 | RTIQQLLM | 0.1 | ||
77 | 14 | RTIQQLLMGTVNIV | 0.5 | ||
81 | 10 | QLLMGTVNIV | 0.55 | ||
82 | 9 | LLMGTVNIV | 0.4 |